139 related articles for article (PubMed ID: 26561347)
1. Dose-Effect Relationship of Alkylating Agents on Testicular Function in Male Survivors of Childhood Lymphoma.
Servitzoglou M; De Vathaire F; Oberlin O; Patte C; Thomas-Teinturier C
Pediatr Hematol Oncol; 2015; 32(8):613-23. PubMed ID: 26561347
[TBL] [Abstract][Full Text] [Related]
2. Ovarian reserve after treatment with alkylating agents during childhood.
Thomas-Teinturier C; Allodji RS; Svetlova E; Frey MA; Oberlin O; Millischer AE; Epelboin S; Decanter C; Pacquement H; Tabone MD; Sudour-Bonnange H; Baruchel A; Lahlou N; De Vathaire F
Hum Reprod; 2015 Jun; 30(6):1437-46. PubMed ID: 25801499
[TBL] [Abstract][Full Text] [Related]
3. Decreasing the number of MOPP courses reduces gonadal damage in survivors of childhood Hodgkin disease.
van den Berg H; Furstner F; van den Bos C; Behrendt H
Pediatr Blood Cancer; 2004 Mar; 42(3):210-5. PubMed ID: 14752856
[TBL] [Abstract][Full Text] [Related]
4. Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood.
van Beek RD; Smit M; van den Heuvel-Eibrink MM; de Jong FH; Hakvoort-Cammel FG; van den Bos C; van den Berg H; Weber RF; Pieters R; de Muinck Keizer-Schrama SM
Hum Reprod; 2007 Dec; 22(12):3215-22. PubMed ID: 17981817
[TBL] [Abstract][Full Text] [Related]
5. Gonadal function in males after chemotherapy for early-stage Hodgkin's lymphoma treated in four subsequent trials by the European Organisation for Research and Treatment of Cancer: EORTC Lymphoma Group and the Groupe d'Etude des Lymphomes de l'Adulte.
van der Kaaij MA; Heutte N; Le Stang N; Raemaekers JM; Simons AH; Carde P; Noordijk EM; Fermé C; Thomas J; Eghbali H; Kluin-Nelemans HC; Henry-Amar M; ;
J Clin Oncol; 2007 Jul; 25(19):2825-32. PubMed ID: 17515571
[TBL] [Abstract][Full Text] [Related]
6. Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma.
Bokemeyer C; Schmoll HJ; van Rhee J; Kuczyk M; Schuppert F; Poliwoda H
Ann Hematol; 1994 Mar; 68(3):105-10. PubMed ID: 8167175
[TBL] [Abstract][Full Text] [Related]
7. The effects of etoposide on testicular function in boys treated for Hodgkin's disease.
Gerres L; Brämswig JH; Schlegel W; Jürgens H; Schellong G
Cancer; 1998 Nov; 83(10):2217-22. PubMed ID: 9827728
[TBL] [Abstract][Full Text] [Related]
8. Gonadal function and fertility in male survivors treated for Hodgkin's disease in Iran.
Rafsanjani KA; Faranoush M; Hedayatiasl AA; Vossough P
Saudi Med J; 2007 Nov; 28(11):1690-3. PubMed ID: 17965791
[TBL] [Abstract][Full Text] [Related]
9. Testicular function of survivors of childhood cancer: a comparative study between ifosfamide- and cyclophosphamide-based regimens.
Ridola V; Fawaz O; Aubier F; Bergeron C; de Vathaire F; Pichon F; Orbach D; Gentet JC; Schmitt C; Dufour C; Oberlin O
Eur J Cancer; 2009 Mar; 45(5):814-8. PubMed ID: 19216070
[TBL] [Abstract][Full Text] [Related]
10. Gonadal status in male survivors following childhood brain tumors.
Schmiegelow M; Lassen S; Poulsen HS; Schmiegelow K; Hertz H; Andersson AM; Skakkebaek NE; Müller J
J Clin Endocrinol Metab; 2001 Jun; 86(6):2446-52. PubMed ID: 11397837
[TBL] [Abstract][Full Text] [Related]
11. Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials.
Behringer K; Mueller H; Goergen H; Thielen I; Eibl AD; Stumpf V; Wessels C; Wiehlpütz M; Rosenbrock J; Halbsguth T; Reiners KS; Schober T; Renno JH; von Wolff M; van der Ven K; Kuehr M; Fuchs M; Diehl V; Engert A; Borchmann P
J Clin Oncol; 2013 Jan; 31(2):231-9. PubMed ID: 23150709
[TBL] [Abstract][Full Text] [Related]
12. Decreased serum inhibin B/FSH ratio as a marker of Sertoli cell function in male survivors after chemotherapy in childhood and adolescence.
Bordallo MA; Guimarães MM; Pessoa CH; Carriço MK; Dimetz T; Gazolla HM; Dobbin J; Castilho IA
J Pediatr Endocrinol Metab; 2004 Jun; 17(6):879-87. PubMed ID: 15270406
[TBL] [Abstract][Full Text] [Related]
13. The effects of different cumulative doses of chemotherapy on testicular function. Results in 75 patients treated for Hodgkin's disease during childhood or adolescence.
Brämswig JH; Heimes U; Heiermann E; Schlegel W; Nieschlag E; Schellong G
Cancer; 1990 Mar; 65(6):1298-302. PubMed ID: 2106384
[TBL] [Abstract][Full Text] [Related]
14. Irreversible gonadal damage in male survivors of pediatric Hodgkin's disease.
Heikens J; Behrendt H; Adriaanse R; Berghout A
Cancer; 1996 Nov; 78(9):2020-4. PubMed ID: 8909325
[TBL] [Abstract][Full Text] [Related]
15. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
16. [Changes in gonadal function in post-pubertal male survivors of acute lymphoblastic leukemia and Hodgkin's disease].
Soriano Guillén L; Muñoz Calvo MT; Pozo Román J; Contra Gómez T; Buño Soto M; Argente Oliver J
An Esp Pediatr; 2000 Oct; 53(4):318-23. PubMed ID: 11083980
[TBL] [Abstract][Full Text] [Related]
17. Effect of childhood cancer treatment on fertility markers in adult male long-term survivors.
van Casteren NJ; van der Linden GH; Hakvoort-Cammel FG; Hählen K; Dohle GR; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2009 Jan; 52(1):108-12. PubMed ID: 18819129
[TBL] [Abstract][Full Text] [Related]
18. [Gonadal function in young men after the treatment for Hodgkin lymphoma].
Krawczuk-Rybak M; Solarz E; Wojtkowska M; Wysocka J; Matysiak M; Gadomski A; Kazanowska B; Sega-Pondel D
Pediatr Endocrinol Diabetes Metab; 2009; 15(2):85-92. PubMed ID: 19772815
[TBL] [Abstract][Full Text] [Related]
19. Low serum inhibin B levels as a marker of testicular damage after treatment for a childhood malignancy.
Cicognani A; Cacciari E; Pasini A; Burnelli R; De Iasio R; Pirazzoli P; Paolucci G
Eur J Pediatr; 2000; 159(1-2):103-7. PubMed ID: 10653341
[TBL] [Abstract][Full Text] [Related]
20. Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood.
van Beek RD; van den Heuvel-Eibrink MM; Laven JS; de Jong FH; Themmen AP; Hakvoort-Cammel FG; van den Bos C; van den Berg H; Pieters R; de Muinck Keizer-Schrama SM
J Clin Endocrinol Metab; 2007 Oct; 92(10):3869-74. PubMed ID: 17726078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
